Publications in collaboration with researchers from Hospital Vall d'Hebron (3)

2025

  1. Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial

    Vaccine, Vol. 47

  2. Safety and immunogenicity of PHH-1V booster against SARS-CoV-2 variants, including omicron subvariants: Results from a phase IIb open-label extension study

    Human Vaccines and Immunotherapeutics, Vol. 21, Núm. 1

2011

  1. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart

    Journal of the American College of Cardiology, Vol. 58, Núm. 9, pp. 977-986